Mayo Clinic

HILTON ROCHESTER CELEBRATES 100 YEARS OF HILTON AND A MEANINGFUL RELATIONSHIP WITH MAYO CLINIC

Retrieved on: 
Tuesday, October 22, 2019
American people of German descent, Conrad Hilton, Hilton, Mayo, American society, Mayo Clinic, Businesspeople, United States

Guests included prominent members of Hilton Corporate and Mayo Clinic as well as influential individuals from the city of Rochester.

Key Points: 
  • Guests included prominent members of Hilton Corporate and Mayo Clinic as well as influential individuals from the city of Rochester.
  • This event was the perfect way to celebrate Hiltons long-lasting relationship with Mayo Clinic, said Andy Chafoulias, Owner of Avra Hospitality.
  • Conrad Hilton, founder of the Hilton Hotels chain, was a loyal patient at Mayo Clinic and enjoyed frequent visits to the city of Rochester.
  • Today, Hilton Rochester Mayo Clinic Area joins the Conrad N. Hilton Building for Laboratory Medicine in service to the city, region, nation and world.

WuXi Diagnostics to open its first research facility in the U.S.

Retrieved on: 
Thursday, September 19, 2019
WuXi AppTec, Articles, Clinic, Mayo, Wuxi, Life sciences, Health, Mayo Clinic

The new facility is located in One Discovery Square, a new health technology and life sciences center in Rochester.

Key Points: 
  • The new facility is located in One Discovery Square, a new health technology and life sciences center in Rochester.
  • The facility is expected to open before the end of the year and will serve as a center for clinical diagnostic testing optimization and development.
  • "Our new facility will directly contribute to our further cooperation with Mayo Clinic," says Jason Liu, Ph.D., Chief Executive Officer of WuXi Diagnostics.
  • WuXi Diagnostics is a joint venture formed in 2018 between WuXi AppTec Group and Mayo Clinic.

Mayo Clinic at the Heart of Healthcare With Rising Number of Innovative Collaborations

Retrieved on: 
Thursday, September 12, 2019
Mayo Clinic, Mayo, Minnesota, States of the United States

The Mayo Clinic has worked long and hard to deserve that perception, which is entirely earned.

Key Points: 
  • The Mayo Clinic has worked long and hard to deserve that perception, which is entirely earned.
  • The people that make up the Clinic may however prefer they are not 'working' but are on a mission.
  • As such Mayo has been partnering with a myriad of technology partners and collaborators that they believe will help them to take even greater strides than before.
  • "We are very pleased to expand our relationship with the outstanding physician team at Mayo Clinic.

Mayo Clinic at the Heart of Healthcare With Rising Number of Innovative Collaborations

Retrieved on: 
Thursday, September 12, 2019
Mayo Clinic, Mayo, Minnesota, States of the United States

The Mayo Clinic has worked long and hard to deserve that perception, which is entirely earned.

Key Points: 
  • The Mayo Clinic has worked long and hard to deserve that perception, which is entirely earned.
  • The people that make up the Clinic may however prefer they are not 'working' but are on a mission.
  • As such Mayo has been partnering with a myriad of technology partners and collaborators that they believe will help them to take even greater strides than before.
  • "We are very pleased to expand our relationship with the outstanding physician team at Mayo Clinic.

Imago Systems Announces Collaboration with Mayo Clinic for Breast Imaging

Retrieved on: 
Wednesday, August 14, 2019
Breast cancer, RTT, Breast imaging, Mayo Clinic, Medical imaging, Health

The multi-year agreement will focus on clinical trial support for Imago Systems' ICE Reveal product for breast imaging and includes financial investment from Mayo Clinic.

Key Points: 
  • The multi-year agreement will focus on clinical trial support for Imago Systems' ICE Reveal product for breast imaging and includes financial investment from Mayo Clinic.
  • Mayo Clinic's involvement will play a critical role in the evolution of the technology to improve breast imaging across multiple imaging modalities.
  • "We are very excited about our collaboration with Mayo Clinic, and its support in advancing our imaging technology for better care.
  • Imago's initial product, Imago ICE Reveal, is designed to support the early detection of breast cancer and other breast abnormalities.

Numerate Receives $2 Million SBIR Phase II Award to Continue Research Using Its AI-Driven Discovery Platform to Identify New Antiarrhythmic Drug

Retrieved on: 
Wednesday, August 7, 2019
Science, Cardiology, Biotechnology, Pharmaceutical, Research, Health, RTT, Medical emergencies, Heart arrhythmia, Heart, Mayo Clinic, Anatomy, Circulatory system, Cardiac arrhythmia, Branches of biology, the Research Team, Cardiac Arrhythmias and Treatment Options, Numerate

Under Phase I funding, the research team applied Numerates AI-driven small molecule drug discovery platform to identify two lead compounds and demonstrate feasibility of the program.

Key Points: 
  • Under Phase I funding, the research team applied Numerates AI-driven small molecule drug discovery platform to identify two lead compounds and demonstrate feasibility of the program.
  • Following the success of our initial research, Phase II will allow us to continue our discovery efforts, with the goal of identifying a new medicine that is safe and effective in preventing and treating serious cardiac arrhythmias.
  • We are thankful for the support from the NIH and are looking forward to continuing our successful partnership with Drs.
  • According to the Mayo Clinic, more than 4 million Americans, most over age 60, experience heart arrhythmias (abnormal heart rhythms) ii.

Thought Leadership & Innovation Foundation and Mayo Clinic’s Limb Loss and Preservation Registry Garners Praise at Amputee Coalition Conference

Retrieved on: 
Thursday, August 1, 2019
Physical therapy, Health, Medical devices, Philanthropy, Foundation, Other Health, Health care, Mayo Clinic, Amputation, Mayo, Clinic, Health

As part of its partnership with Mayo Clinic in the development of a Limb Loss and Preservation Registry (Registry) for the National Institute of Child Health and Human Development (NICHD), the Thought Leadership & Innovation Foundation (TLI) supported the Mayo Clinic participation at the Amputee Coalitions 2019 National Conference in San Antonio, Texas.

Key Points: 
  • As part of its partnership with Mayo Clinic in the development of a Limb Loss and Preservation Registry (Registry) for the National Institute of Child Health and Human Development (NICHD), the Thought Leadership & Innovation Foundation (TLI) supported the Mayo Clinic participation at the Amputee Coalitions 2019 National Conference in San Antonio, Texas.
  • There was palpable enthusiasm for the development of the Registry and how it can bring value to the community.
  • With record high conference attendance, 1,300+ people from the limb loss and limb difference community benefitted from educational and motivational sessions, hands-on clinics and introductions to companies that are active in this space.
  • This annual event embodies the mission of the Amputee Coalition to educate and support this community and help members be effective advocates.

Mayo Clinic to Collaborate with Viome on AI-Driven Personalized Nutritional Strategies to Help Understand Sleep and Obesity

Retrieved on: 
Thursday, July 25, 2019
Mayo, Mayo Clinic, Minnesota

SEATTLE, July 25, 2019 /PRNewswire/ -- Viome, a company transforming health through personalized nutrition based on individual biology, today announces a collaboration with Mayo Clinic.

Key Points: 
  • SEATTLE, July 25, 2019 /PRNewswire/ -- Viome, a company transforming health through personalized nutrition based on individual biology, today announces a collaboration with Mayo Clinic.
  • The study will focus on measures of obesity (including body fat %), metabolism (HbA1c), and sleep.
  • The teams will leverage Mayo Clinic's medical expertise and Viome's proprietary microbiome analysis platform.
  • Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

MemorialCare Joins Innovative Effort to Solve Nation's Drug Shortage

Retrieved on: 
Wednesday, July 17, 2019
Fountain Valley, California, Mayo Clinic, Hospital, Geography of California, Long Beach Memorial Medical Center

MemorialCare joins other prominent health systems, including Mayo Clinic, to sign on with Civica.

Key Points: 
  • MemorialCare joins other prominent health systems, including Mayo Clinic, to sign on with Civica.
  • "Civica's new, highly-collaborative approach is needed to solve America's drug shortage crisis," says Barry Arbuckle, PhD, MemorialCare President & CEO.
  • MemorialCare continues to revolutionize healthcare with rapid movement to convenient, less costly and high-quality outpatient centers.
  • MemorialCare also includes top-rated community hospitals MemorialCare Orange Coast Medical Center in Fountain Valley and MemorialCare Saddleback Medical Center in Laguna Hills, and centers for teaching future physicians, nurses and other clinicians.

Digital therapeutics leader Biofourmis to take part in pioneering heart failure research with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI)

Retrieved on: 
Tuesday, July 16, 2019
Mayo Clinic, Food and Drug Administration, Health, Minnesota

BOSTON, July 16, 2019 /PRNewswire/ -- Biofourmis , a fast-growing global leader in digital therapeutics, has entered a research partnership with the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI) .

Key Points: 
  • BOSTON, July 16, 2019 /PRNewswire/ -- Biofourmis , a fast-growing global leader in digital therapeutics, has entered a research partnership with the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI) .
  • "This joint project has the potential to advance the science of clinical trial design," said Kuldeep Singh Rajput, CEO of Biofourmis.
  • The Yale-Mayo CERSI is a joint effort between Yale University, Mayo Clinic and the U.S. Food & Drug Administration (FDA).
  • CERSIs are collaborations between FDA and academic institutions to advance regulatory science through innovative research, training and scientific exchanges.